The antimicrobial agent epifadin, which is produced by the nasal commensal Staphylococcus epidermidis, has— despite its short half-life — broad-spectrum activity, including against Staphylococcus aureus.
References
Sorbara, M. T. & Pamer, E. G. Nat. Rev. Microbiol. 20, 365–380 (2022).
Gavriilidou, A. et al. Nat. Microbiol. 7, 726–735 (2022).
Torres Salazar, B. O. et al. Nat. Microbiol. https://doi.org/10.1038/s41564-023-01544-2 (2023).
Dougherty, M. W. & Jobin, C. Toxins 13, 346 (2021).
Heilbronner, S., Krismer, B., Brötz-Oesterhelt, H. & Peschel, A. Nat. Rev. Microbiol. 19, 726–739 (2021).
Barbour, A., Wescombe, P. & Smith, L. Trends Microbiol. 28, 578–593 (2020).
Zipperer, A. et al. Nature 535, 511–516 (2016).
Joyner, P. M. et al. Org. Biomol. Chem. 8, 5486–5489 (2010).
Walesch, S. et al. EMBO Rep. 24, e56033 (2023).
Hirsch, P. et al. Nuc. Acids Res. https://doi.org/10.1093/nar/gkad1086 (2023).
Mullowney, M. W. et al. Nat. Rev. Drug Discov. 22, 895–916 (2023).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
R.M. and A.K. are co-founders of MooH GmbH, a company that develops oral metagenomic diagnostics and probiotics.
Rights and permissions
About this article
Cite this article
Beemelmanns, C., Keller, A. & Müller, R. Mining the microbiota for antibiotics. Nat Microbiol 9, 13–14 (2024). https://doi.org/10.1038/s41564-023-01568-8
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41564-023-01568-8
- Springer Nature Limited